Our Mission and Vision

ThermEval's objective is to significantly reduce the incidence of heart attacks, strokes and thyroid disorders with widespread ACT Examination screenings. Our vision is improved patient mortality and reduced public cost of dealing with these health issues.

Heart attacks, strokes and thyroid disorders are secondary complications of coronary artery atherosclerosis, carotid stenosis, and thyroid dysfunction. The clinical symptoms of these diseases are three of the four leading causes of death for those 65 and over.

The first wave of the 76-million Baby Boomers turned 65 in 2011. The expected dramatic increase in afflicted older patients has begun, and with it, increased public cost. Medicare projects that by 2020 the cost of treating the clinical complications of these diseases will soar to $400 billion, or forty-percent of Medicare's $1 trillion estimated total cost.

Many clinical episodes may be avoided if their underlying disease is detected and treated early enough. Regrettably, the high cost of comprehensive screening is not covered by Medicare, except for high risk or clinically symptomatic patients and the financial burden is typically deferred by the patient.

For $225 (about 5% of the cost of comprehensive screenings), the ACT Examination reveals previously-occult symptoms of the diseases and answers the question, 'Is the patient demonstrably at elevated risk and indicating a need for further comprehensive screening?' '

We're confident that widespread ACT Examination screenings will reveal symptoms of the underlying diseases while they are still subclinical. Treating these diseases will improve patient mortality and reduce long-term public cost.


Fulfilling our objectives requires wide distribution of Thermal Imaging Systems and local campaigns to motivate patients to seek a local certified practitioner for an ACT Examination.

Marketing to Practitioners

Thermal Imaging System purchases are facilitated by our (Gillette's) philosophy of 'give away the expensive razor and make money by selling large quantities of inexpensive razor blades.' Our 'give-away' is the low cost Model 325 Thermal Imaging System attractively priced at a fraction of competing systems and available with favorable financing and free on-site training (within the USA). Our 'inexpensive blades' are competitively priced image interpretation services provided by Thermogram Assessment Services.

Many patients are unaware they may be at serious risk and in need of treatment to thwart potential disaster. These 'hidden risks' belong to those at elevated risk, but not categorized high risk by their 'Welcome to Medicare' preventative screening.

'Hidden risk' patients who desire further study are faced with costly comprehensive examinations that are not covered by Medicare. The ACT Examination is promoted as an affordable method for determining whether or not further examinations are indicated, and if they are, positive ACT Examination findings can be a bridge to covered comprehensive clinical procedures.

The patient-directed awareness campaign promotes the notion of 'hidden risks' and how sudden catastrophe may be avoided by undergoing an inexpensive ACT Examination to detect signs of occult diseases while they are still treatable. Campaigns motivating patients to seek and undergo the ACT Examination are conducted locally in behalf of the local practitioner's practice.